Board & Governance
A finance and governance perspective for the boardroom.
David is interested in contributing to Supervisory Boards, Boards of Directors and Audit & Risk Committees, particularly in innovative, international, private equity-backed and growth-oriented companies.
What David brings to a board
Financial depth, applied with independence and judgement.
As a serving CFO, David sees governance from the management side every day: how reporting is produced, how controls work in practice, and how auditors, investors and lenders engage with the business. That experience is directly relevant to effective oversight.
He combines this with sector knowledge in biotechnology and life sciences and a practical understanding of AI and digital transformation, areas where many boards are seeking stronger expertise.
- Independent strategic perspective and financial judgement
- Financial reporting, audit and internal control oversight
- Enterprise risk management and governance
- Capital allocation and financial sustainability
- Digital transformation and emerging technology risks
- Private equity and growth-company perspectives
- Biotechnology and life sciences industry knowledge
- Constructive engagement with management, auditors, investors and stakeholders
Roles of interest
Where David can contribute.
Non-Executive Director
Independent board roles where financial expertise, strategy and governance experience support long-term value creation.
Supervisory Board
Supervisory roles in two-tier board structures, with a focus on financial oversight, accountability and constructive challenge.
Audit & Risk Committee
Oversight of financial reporting quality, IFRS, internal controls, external audit and enterprise risk management.
Governance focus
Frameworks and principles.
David's governance focus covers corporate governance and board effectiveness, financial reporting and IFRS, internal controls and accountability, enterprise risk management and regulatory compliance. He draws on established frameworks, including the OECD Principles of Corporate Governance and COSO, as well as SOX-related control practices.
Sectors of particular interest include biotechnology, life sciences, healthcare, technology and private equity-backed companies.
David does not currently list independent board appointments. This page sets out his board readiness and interest in future opportunities.
Let's connect